AU2001242985A1 - New combination of a betablocker and a cholesterol-lowering agent - Google Patents
New combination of a betablocker and a cholesterol-lowering agentInfo
- Publication number
- AU2001242985A1 AU2001242985A1 AU2001242985A AU2001242985A AU2001242985A1 AU 2001242985 A1 AU2001242985 A1 AU 2001242985A1 AU 2001242985 A AU2001242985 A AU 2001242985A AU 2001242985 A AU2001242985 A AU 2001242985A AU 2001242985 A1 AU2001242985 A1 AU 2001242985A1
- Authority
- AU
- Australia
- Prior art keywords
- betablocker
- cholesterol
- lowering agent
- new combination
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003529 anticholesteremic agent Substances 0.000 title 1
- 239000002876 beta blocker Substances 0.000 title 1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0001188-2 | 2000-04-03 | ||
SE0001188A SE0001188D0 (en) | 2000-04-03 | 2000-04-03 | New combination |
SE0002352-3 | 2000-06-22 | ||
SE0002352A SE0002352D0 (en) | 2000-06-22 | 2000-06-22 | New combination |
PCT/SE2001/000663 WO2001074394A1 (en) | 2000-04-03 | 2001-03-27 | New combination of a betablocker and a cholesterol-lowering agent |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001242985A1 true AU2001242985A1 (en) | 2002-01-03 |
AU2001242985B2 AU2001242985B2 (en) | 2005-02-24 |
Family
ID=26655059
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001242985A Ceased AU2001242985B2 (en) | 2000-04-03 | 2001-03-27 | New combination of a betablocker and a cholesterol-lowering agent |
AU4298501A Pending AU4298501A (en) | 2000-04-03 | 2001-03-27 | New combination of a betablocker and a cholesterol-lowering agent |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU4298501A Pending AU4298501A (en) | 2000-04-03 | 2001-03-27 | New combination of a betablocker and a cholesterol-lowering agent |
Country Status (25)
Country | Link |
---|---|
US (2) | US20030060477A1 (en) |
EP (1) | EP1272219B1 (en) |
JP (1) | JP2003528928A (en) |
KR (1) | KR20020086749A (en) |
CN (1) | CN1422161A (en) |
AR (1) | AR030414A1 (en) |
AT (1) | ATE347909T1 (en) |
AU (2) | AU2001242985B2 (en) |
BR (1) | BR0109753A (en) |
CA (1) | CA2403160A1 (en) |
DE (1) | DE60125159T2 (en) |
EE (1) | EE200200570A (en) |
ES (1) | ES2276774T3 (en) |
HK (1) | HK1051325A1 (en) |
HU (1) | HUP0300332A3 (en) |
IL (1) | IL151589A0 (en) |
IS (1) | IS6554A (en) |
MX (1) | MXPA02009705A (en) |
MY (1) | MY136386A (en) |
NO (1) | NO20024732L (en) |
NZ (1) | NZ521351A (en) |
PL (1) | PL357813A1 (en) |
RU (1) | RU2002123591A (en) |
SK (1) | SK14102002A3 (en) |
WO (1) | WO2001074394A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7790197B2 (en) | 2003-06-09 | 2010-09-07 | Warner-Lambert Company Llc | Pharmaceutical compositions of atorvastatin |
US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
ITMI20040145A1 (en) * | 2004-01-30 | 2004-04-30 | Acraf | L-MOPROLOLO LPIU 'TARTRATO |
EP1722758A1 (en) * | 2004-02-11 | 2006-11-22 | Athpharma Limited | Chronotherapeutic compositions and methods of their use |
CN102091068B (en) * | 2004-05-03 | 2012-09-19 | 詹森药业有限公司 | Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS) |
CN101022791B (en) * | 2004-06-04 | 2011-11-16 | 麦兰实验室公司 | Compositions comprising nebivolol |
BRPI0621942A2 (en) | 2006-08-04 | 2011-10-18 | Aska Pharm Co Ltd | a preparation which reduces a concentration of a free fatty acid and / or fibrinogen in the blood, an agent for reducing the amount of a free fatty acid in the blood, an agent for reducing the amount of fibrinogen in the blood, a method for preventing or treating hyperacidemia of free fatty acid, metabolic syndrome, type II diabetes, complications caused by type II diabetes, lipotoxicity, abnormal lipid metabolism, glucose intolerance, impaired insulin secretion, liver fat, hypo-high density lipoproteinemia, or thrombosis, and use of a preparation |
GB0624282D0 (en) * | 2006-12-05 | 2007-01-10 | Cavalla David | Treatment of cachexia |
KR20100045344A (en) * | 2008-10-23 | 2010-05-03 | 한올바이오파마주식회사 | Novel controlled release pharmaceutical combination composition comprising the beta adrenoceptor-blockers and the hmg-coa reductase inhibitors |
MX344885B (en) * | 2008-11-10 | 2017-01-10 | Psicofarma S A De C V | Process for obtaining a composition of rosuvastatin calcium and product obtained. |
CN102462844A (en) * | 2010-11-05 | 2012-05-23 | 四川滇虹医药开发有限公司 | Tilisolol pharmaceutical composition and its preparation method |
WO2013157833A1 (en) * | 2012-04-18 | 2013-10-24 | 서울대학교산학협력단 | Composition including beta-blocker as an active principle for treating or improving obesity, metabolic diseases, and osteopenia |
CN103613586B (en) * | 2013-11-01 | 2016-06-08 | 北京博爱旺康医药科技有限公司 | A kind of pure S-of optically-active (-)-arotinolol acid salt and its preparation method and application |
CN103626750B (en) * | 2013-11-15 | 2016-02-24 | 北京博爱旺康医药科技有限公司 | A kind of Arotinolol Hydrochlorid and preparation method thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175187A (en) * | 1989-03-06 | 1992-12-29 | Soorianarain Baligadoo | Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
US5455269A (en) * | 1989-03-06 | 1995-10-03 | Baligadoo; Soorianarain | Synergistic compositions of amiodarone and beta blockers |
DE69212646T2 (en) * | 1991-03-18 | 1997-03-13 | Sepracor Inc | PREPARATION AND PROCESS CONTAINING OPTICALLY PURE S-METOPROLOL |
JP2648897B2 (en) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | Pyrimidine derivatives |
NO177455C (en) * | 1993-06-04 | 1995-09-20 | Gerrit Elmenhorst | Device for apparatus for making fire-extinguishing foam |
CA2251972A1 (en) * | 1996-04-17 | 1997-10-23 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
SE9602762D0 (en) * | 1996-07-12 | 1996-07-12 | Astra Ab | Carton and blank for forming the same |
US5998458A (en) * | 1997-06-25 | 1999-12-07 | University Technology Corporation | Method of treating heart failure |
GT199800126A (en) * | 1997-08-29 | 2000-01-29 | COMBINATION THERAPY. | |
EP1354604A1 (en) * | 1998-12-23 | 2003-10-22 | G.D. Searle LLC. | Combinations for cardiovascular indications |
-
2001
- 2001-03-21 AR ARP010101322A patent/AR030414A1/en unknown
- 2001-03-27 US US10/220,790 patent/US20030060477A1/en not_active Abandoned
- 2001-03-27 BR BR0109753-9A patent/BR0109753A/en not_active IP Right Cessation
- 2001-03-27 CA CA002403160A patent/CA2403160A1/en not_active Abandoned
- 2001-03-27 AT AT01916044T patent/ATE347909T1/en not_active IP Right Cessation
- 2001-03-27 CN CN01807652A patent/CN1422161A/en active Pending
- 2001-03-27 EP EP01916044A patent/EP1272219B1/en not_active Expired - Lifetime
- 2001-03-27 DE DE60125159T patent/DE60125159T2/en not_active Expired - Fee Related
- 2001-03-27 NZ NZ521351A patent/NZ521351A/en unknown
- 2001-03-27 JP JP2001572136A patent/JP2003528928A/en active Pending
- 2001-03-27 PL PL01357813A patent/PL357813A1/en unknown
- 2001-03-27 ES ES01916044T patent/ES2276774T3/en not_active Expired - Lifetime
- 2001-03-27 AU AU2001242985A patent/AU2001242985B2/en not_active Ceased
- 2001-03-27 IL IL15158901A patent/IL151589A0/en unknown
- 2001-03-27 AU AU4298501A patent/AU4298501A/en active Pending
- 2001-03-27 MX MXPA02009705A patent/MXPA02009705A/en unknown
- 2001-03-27 RU RU2002123591/15A patent/RU2002123591A/en not_active Application Discontinuation
- 2001-03-27 KR KR1020027013184A patent/KR20020086749A/en not_active Application Discontinuation
- 2001-03-27 WO PCT/SE2001/000663 patent/WO2001074394A1/en not_active Application Discontinuation
- 2001-03-27 SK SK1410-2002A patent/SK14102002A3/en not_active Application Discontinuation
- 2001-03-27 HU HU0300332A patent/HUP0300332A3/en unknown
- 2001-03-27 EE EEP200200570A patent/EE200200570A/en unknown
- 2001-04-02 MY MYPI20011564A patent/MY136386A/en unknown
-
2002
- 2002-09-19 IS IS6554A patent/IS6554A/en unknown
- 2002-10-02 NO NO20024732A patent/NO20024732L/en unknown
-
2003
- 2003-05-23 HK HK03103659A patent/HK1051325A1/en not_active IP Right Cessation
-
2004
- 2004-04-14 US US10/824,170 patent/US20040192784A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001285020A1 (en) | P97-active agent conjugates and their methods of use | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU2002223275A1 (en) | A method of expression and agents identified thereby | |
AU2001242985A1 (en) | New combination of a betablocker and a cholesterol-lowering agent | |
AU2001281006A1 (en) | Combination of huperzine and nicotinic compounds as a neuroprotective agent | |
AU4298501A (en) | New combination of a betablocker and a cholesterol-lowering agent | |
AU3622600A (en) | Metalloproteinases and methods of use therefor | |
AU2001235506A1 (en) | Dermatological use and a dermatological preparation | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
IL144662A0 (en) | Use of cholesterol-lowering agent | |
AU1053501A (en) | Polyazanaphthalene compound and medicinal use thereof | |
AU4432001A (en) | Trityl-type compounds and their use | |
IL153245A0 (en) | New formulation comprising a betablocker and optionally a cholesterol-lowering agent | |
AU2001234180A1 (en) | Benzamide derivative and use thereof | |
AU2001239631A1 (en) | A new oligomer compound and a use thereof | |
ZA200207107B (en) | New combination of a betablocker and a cholesterol-lowering agent. | |
AU2001288196A1 (en) | Tracheostomy tube and use of a coniostomy tube as a tracheostomy tube | |
AU2001252710A1 (en) | Chemically amplified resist and a resist composition | |
AU2000274552A1 (en) | An open construction of a can | |
AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
AU2002215923A1 (en) | Use of medicaments | |
AU2001255708A1 (en) | Synthesis and use of thienotriazolodiazepines | |
AU2002223707A1 (en) | A new use of a pyridazinone derivative |